Perkasie, Penna. – May 10, 2013 – In a black-tie gala attended by more than 900 business leaders and companies in advanced technology, Secant Medical, Inc. received the MedTech Leadership Award at the 20th Annual Enterprise Awards. The company accepted the honor from the Greater Philadelphia Alliance for Capital and Technologies (PACT) during a ceremony at Valley Forge Casino Thursday evening.

Secant Medical was selected for its industry vision and leadership, ability to attract and retain talent, and involvement in the local community. “Secant Medical’s core principles inspire an environment of proactive employee engagement and constructive feedback, and our approach to transparent communication has strengthened our relationships with clients,” said Erik Nadeau, president of Secant Medical. “Our long-term vision for growth in the global medical device industry has positioned us to be at the forefront of biomaterials development. As partners in device manufacturing, we are committed to advancing products that improve patient lives.”

PACT serves as a hub for emerging growth companies, investors, advisors, and technology corporations involved in the technology and life sciences industries. Its mission is to promote organizations located in the Greater Philadelphia region.

About Secant Medical: Secant Medical® designs and manufactures biomedical textiles and other structures for medical devices.Employing medical fabric engineering technologies, we blend polymeric, metallic and resorbable biomaterials to create custom, high-performance structures that are used in the cardiovascular, general surgery, neurovascular, orthopedic and regenerative medicine fields. Built on a 70-year history, we’re committed to the future of biomaterials and their role in the healing process and are actively engaged in research partnerships to advance next-generation biomaterial development. Secant Medical is a business unit of Fenner PLC, a worldwide leader in reinforced polymer engineering headquartered in Yorkshire, England. For more information, contact Maria Fontanazza at 215-257-8680 x2192 or [email protected]; or visit

View website